FLUCELVAX TETRA av aigu 2024/2025 ser pré 0.5 ml
7680674820055
CH-67482
J07BB02
08.08.
Reimbursement limitations:
0808 NEU
La prise en charge des coûts des vaccins au titre de mesure préventive dans le …
1 / 3
google
Details
- Product number
- 6748202
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- haemagglutininum influenzae A (H1N1) (Virus Stamm A/Wisconsin/67/2022 (H1N1)-like: derived from A/Georgia/12/2022 CVR-167) 15 µg, haemagglutininum influenzae A (H3N2) (Virus Stamm A/Massachusetts/18/2022 (H3N2)-like: derived from A/Sydney/1304/2022) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Austria/1359417/2021-like: reassortant from B/Singapore/WUH4618/2021 (Victoria lineage)) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Phuket/3073/2013-like: reassortant from B/Singapore/INFTT-16-0610/2016 (Yamagata lineage)) 15 µg, natrii chloridum, kalii chloridum, magnesii chloridum hexahydricum, natrii dihydrogenophosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.7 mg, kalium 0.1 mg, residui: polysorbatum 80, cetrimidum, propiolactonum.
Articles (1)
Flucelvax Tetra, Injektionssuspension
Injektionssuspension
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.7 MG | Substance | HBESI |
|
(N/A)
|
0.1 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | RESI |
|
(N/A)
|
- | Substance | RESI |
|
(N/A)
|
- | Substance | RESI |
Authorization holder
Vifor (International) Inc.
9014 St. Gallen
Authorization information
- Swissmedic authorization number
- 67482
- Drug name
- Flucelvax Tetra, Injektionssuspension
- Galenic form
- INJFS
- ATC Code
- J07BB02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 04/05/2021
- Authorization expiration date
- 03/05/2026
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FLUCELVAX TETRA av aigu 2024/2025 ser pré 0.5 ml
- Description (DE)
- FLUCELVAX TETRA m Nadel 2024/2025 Fertspr 0.5 ml
- Market launch
- 19/07/2024
- Narcotic (BTM)
- No